Hyperglycemia is well known to accelerate the chemical formation of early glycosylation products with protein (Schiff bases and Amadori products) in diabetic subjects (1) . Some (3) . Recently, the accumulated evidence has shown that the net increase in AGE levels of long-lived proteins in diabetic animals might be correlated with the pathological lesions of several tissues such as lens crystallins (4) , renal cortex (4, 5) and aorta (6) . This information came from the determination of tissue levels of AGE using an ELISA specific to the AGE. Our previous study (4) comparing two assay methods has shown that the mean AGE level in lens crystallins of diabetic rats was increased by more than 12-fold estimated by ELISA but less than two-fold by fluorescence, indicating that ELISA was more sensitive than the fluorescence level.
Although aminoguanidine (AG) is known as an inhibitor of AGE formation, the experimental evidence for this is based on the several indirect observations carried out in vitro (7) . There has been only one in vivo report (8) demonstrating that AG prevented AGE formation in hemoglobin of diabetic patients in a 28-day phase I clinical trial with AG, whereas there are many reports that have examined the therapeutic potential of AG in the treatment of experimental diabetic complications. Aminoguanidine ameliorated proteinuria (9, 10) and increased the thickness of the glomerular basement membrane (11 
Electrophysiology
The MNCV was measured using the method described by Sharman and Thomas (14) . In 16 (Fig. 1) (3, 4) . As shown in Fig. 3 
Discussion
In the present study we have shown that AG treatment for 16 weeks improved slowing of the MNCV in diabetic rats in a dose-dependent manner (Fig. 1 ). This occurred in the absence of any effects on body weight and blood glucose levels (Table 1) , morphometric changes in the sciatic nerve (Table 2 ) and nerve Na+,K+-ATPase activity (Table 3 ). There are no lack of theories linking activated polyol metabolism to the progression of diabetic complications (17, 18 (21) and ponalrestat also showed the same effects at 4 weeks (22) . In this study, AG significantly increased the MNCV at 16 weeks after AG treatment in a dose-dependent manner but was ineffective until 12 weeks (Fig. 1) . This is compatible with previous reports (12, 13) (Fig. 3) . The (Fig. 4) . This finding is consistent with the observations made by Yagihashi et al. (13) , suggesting that a decrease in the MNCV in diabetic rats may be due, in part, to an increase in the AGE content in nerve.
Although ELISA for AGE-protein is a more specific and sensitive assay than the fluorescence assay, the numbers of tissues to which ELISA is applicable are limited in the tissues such as lens crystallins (4), renal cortex (4, 5) and aorta (6) . To (Table  2 ). This is consistent with the early report by Sharma and Thomas, showing that the myelinated fiber population of the sural and tibial nerves in diabetic rats showed no loss of fibers or reduction in their caliber (14) . We 
